Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

Between now and the interim human trial report IPIX investors can expect a series of positive PR's which will outline Brilacidin's FDA review, foreign and domestic human clinical plans,
clinical trial protocols, and other details which will lead to press coverage in anticipation of the interim trial report.

Covid 19 is a worldwide scourge which is destroying individual health, health care systems and economies. Unfortunately we are on the verge of expotenial spread of Corona virus which will tax much of the nations health facilities much in the same way New York City and Italy was tested early in the pandemic. If Brilacidin's human trials confirm the in vitro testing it will be the Coronavirus antiviral of choice and a cornerstone of any Covid19 treatment regimen.

The next 6 weeks are going to be exciting for Ipix shsreholders.

Jmo

Glta, Farrell